发明名称 Phospholipid Ether Analogs as Cancer-Targeting Drug Vehicles
摘要 The present invention is directed to therapeutic compounds capable of targeting cancer cells and cancer stem cells. The present invention is further directed to compositions comprising these therapeutic compounds and methods of treating cancer comprising administering these therapeutic compounds.
申请公布号 US2016136290(A1) 申请公布日期 2016.05.19
申请号 US201514934203 申请日期 2015.11.06
申请人 Cellectar Biosciences, Inc. 发明人 Weichert Jamey P.;Pinchuk Anatoly;Kozak Kevin;Longino Marc;Grudzinski Joseph;Titz Benjamin;Pak Chorom;Stehle Nathan
分类号 A61K47/48;A61K31/395;A61K31/537;A61K31/337 主分类号 A61K47/48
代理机构 代理人
主权项 1. A therapeutic compound comprising the formula A-B-D wherein: A is at least one compound of formula (I),at least one compound of formula (II),at least one compound of formula (III)or a combination thereof, wherein W is selected from the group consisting of an aryl, a C1-C6 alkyl, an alkenyl, an optionally substituted C3-C6 cycloalkyl and an optionally substituted C3-C6 heterocycloalkyl, wherein R is H or an alkyl and wherein m is an integer from 12 to 24; B is a linker compound; and D is an anti-cancer drug,wherein the ratio of A to D is from 1:2 to 2:1.
地址 Madison WI US